Efient 10 mg film-coated tablets.
Sponsors
Rigshospitalet, St Antonius Hospital, Wellbeing Services County Of North Karelia Siun Sote, Centre Hospitalier Universitaire De Caen Normandie, Fundacion Epic
Conditions
Acute Myocardial InfarctionCARDIOVASCULAR DISEASESChronic coronary syndromeCoronary artery diseaseElderly patients ≥ 65 years successfully treated with percutaneous coronary intervention (PCI) with ≥ 1 drug-eluting stent for acute or chronic coronary syndromeMyocardial infarctionStable coronary artery disease
Phase 3
Phase 4
Reduced antithrombotic strategy for high bleeding risk patients with myocardial infarction treated with percutaneous coronary intervention - The Dan-DAPT trial
RecruitingCTIS2022-500125-32-00
Start: 2022-06-20Target: 2700Updated: 2025-11-18
Pharmacodynamic Outcomes in patients with coronary artery disease undergoing Percutaneous coronary intervention treated with an individualized treatment STRATEGY (POPular STRATEGY PD)
RecruitingCTIS2023-504078-39-01
Start: 2024-01-11Target: 88Updated: 2024-08-26
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)
RecruitingCTIS2023-504340-34-01
Start: 2024-01-11Target: 734Updated: 2025-06-26
Body Weight Adjusted Clopidogrel treatment in patients with CORonary artery Disease (BW-ACCORD)
Not yet recruitingCTIS2024-518890-33-00
Target: 80Updated: 2024-11-12
Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in
Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)
CompletedCTIS2024-519854-35-00
Start: 2021-06-29End: 2025-03-24Target: 695Updated: 2025-04-14
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneous coronary intervention.
Not yet recruitingCTIS2023-507545-28-00
Target: 1700Updated: 2025-03-27